POSTER SESSION V Wednesday, March 2, 2005   —  9:30 AM - 12:00 Noon Convention Center, Exhibit Hall B HEMATOPATHOLOGY 158 Gene Expression Profiling of EBV Positive- and Negative- Cases of Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder (1053) FE Craig, LR Johnson, SAK Harvey, MA Nalesnik, JH Luo, SD Bhattacharya, SH Swerdlow - University of Pittsburgh School of Medicine; Pittsburgh, PA 159 Post-Transplant Lymphoproliferative Disorder after Umbilical Cord Blood Transplantation in Children: A Study of 6 Cases (1071) JZ Gong, MG Bayerl, LM Sandhaus, S Sebastian, AS Lagoo, J Chiu, M Comito, P Szabolcs, M Routbout, PJ Buckley - Duke University Medical Center, Durham, NC; M.S. Hershey Medical Center, Hershey, PA; University Hospitals of Cleveland, Cleveland, OH 160 Simian Virus 40 (SV40) in Post-Transplant Lymphoproliferative Disorders (1092) MP Jauregui, RA Vilchez, ED Hsi, V Shidham, C Chang - Escuela de Medicina Ignacio A. Santos Monterrey, Mexico; Baylor College of Medicine, Houton, TX; The Cleveland Clinic, Cleveland, OH; Medical College of Wisconsin, Milwaukee, WI; The Methodist Hospital, Houston, TX 161 Small Lymphocytic Lymphoma as a Clinically Distinct Entity: Our Institutional Experience with IgH V Gene Hypermutation Status in 34 Cases (1082) A Hassan, S Haymond, BA Zehnbauer, R Burack - Washington University School of Medicine, St. Louis, MO 162 Real-Time RT-PCR Evaluation of Cyclin D1 mRNA Expression in Mantle Cell Lymphoma Present in Archived Bone Marrow Biopsy Specimen (1091) A Iyer, C Johnson, C Bifulco, P Hui - Yale University School of Medicine, New Haven, CT 163 Primary CNS Low-Grade B-Cell Lymphoma: A Case Series with FISH Analysis (1110) MO Leavitt, JE Wrede, H Vogel, AM Cherry, DA Arber, TI George - Stanford University Medical Center, Stanford, CA 164 DNA Polymerases m, z and h Gene Expression in B-Cell Non-Hodgkin's Lymphomas (1051) SM Chung, YL Wang, A Chiu, E Cesarman, DM Knowles - Weill Medical College of Cornell University, New York, NY 165 Cancer-Testis Antigens (CTs) Are Associated with Proliferation in MGUS and Myeloma but Are Not Expressed by Lymphocytes or Non-Hodgkin Lymphomas (1055) D Czuchlewski, AA Jungbluth, YT Chen, HJ Cho, DM Knowles, SA Ely - Weill Medical College of Cornell University, New York, NY; Memorial Sloan Kettering Cancer Center, New York, NY 166 B Cell Specific Activation Protein Encoded by the PAX-5 Gene Is Commonly Expressed in Carcinomas of Neuroendocrine Origin (1059) HY Dong, W Liu, P Cohen, CE Mahle, W Zhang - Genzyme Genetics/IMPATH, New York, NY 167 Tumor-Selective Measurement of Cell Proliferation by Ki-67 and DNA S-Phase in Non-Hodgkin B-Cell Lymphoma: Are the Two Methods Equivalent? (1109) DK Kurylo, RC Braylan, Y Li, LJ Yang, VK Douglas-Nikitin - University of Florida, Gainesville, FL 168 BAFF-R, the Major B Cell-Activating Factor Receptor, Is Expressed on the Majority of Mature B Cells and B Cell Lymphoproliferative Disorders (1154) SJ Rodig, A Shahsafaei, DM Dorfman - Brigham & Women's Hospital, Boston, MA 169 The Correlation Dimension Identifies B-Cell Immunoglobulin Light Chain Restriction in Flow Cytometry Data (1187) NT Wongchaowart, DG Rinehart, ED Hsi - The Cleveland Clinic Foundation, Cleveland, OH 170 ZAP-70 Expression in B-Cell Lymphoid Neoplasms: An Immunohistochemical Study (1042) J Carreras, N Villamor, L Colomo, C Moreno, D Colomer, E Campo - Hospital Clinic (IDIBAPS), Badalona, Spain 171 Zeta-Associated Protein-70 Expression in B Cell Lymphomas by Flow Cytometry (1123) C Montalvo, Y Zu, G Zeng, A Ponce de Leon, A Ewton, C Chang - Baylor College of Medicine, Houston, TX; The Methodist Hospital, Houston, TX 172 CD13 Expression by IGM-Producing Low Grade B-Cell Lymphomas (1137) SI Park, J Bell, KP Mann, JT Holden - Emory University School of Medicine, Atlanta, GA 173 Evaluation of the BLIMP-1 Protein in Non-Hodgkin Lymphomas and Plasma Cell Neoplasms Reveals Unexpected Patterns of Expression (1136) CY Park, C Tunyaplin, KL Calame, Y Natkunam - Stanford University School of Medicine, Stanford, CA; Columbia University College of Physicians and Surgeons, New York, NY 174 Activation of the Plasma Cell Associated Transcription Factor XBP-1 in B-Cell NHL (1117) A Martinez, S Pittaluga, M Rudelius, T Fountaine, ES Jaffe, M Raffeld - National Cancer Institute, Bethesda, MD; Hospital del Mar, Barcelona, Spain 175 Characterisation of a New Monoclonal Antibody Recognising CD11c in Paraffin-Embedded Tissue (1183) L Venkatraman, KA McDonald, E Bagdi, L Krenacs, N Piggott, G McIntosh, A Dogan - Royal Victoria Hospital, Belfast, U. K.; Bay Zoltan Foundation for Applied Research, Szeged, Hungary; Novocastra Laboratories, Newcastle, U.K.; University College London, London, U. K. 176 The nm23 Protein Expression Is Associated with Poor Prognosis in Non-Hodgkin's Lymphomas (1101) I Kim, JH Lee, S Cho, X Zhang - Korea University Medical College, Seoul, Korea 177 KOC (K Homology Domain Containing Protein Over-Expressed in Cancer) Expression in Lymphomas (1190) P Wu, RK Yantiss, Z Jiang, GR Fanger, BA Woda - UMass Memorial Medical Center, Worcester, MA; Corixa Corporation, Seattle, WA 178 Pokemon Protein Characterization and Expression in B and T-Cell Lymphomas (1173) J Teruya-Feldstein, T Maeda, R Hobbs, T Merghoub, I Guernah, A Zelenent, P Pandolfi - Memorial Sloan-Kettering Cancer Center, New York, NY; Institute of Cancer Research, London, United Kingdom 179 Assessment of BIOMED-2 PCR Protocols for B and T Cell Clonality Analyses in Routine Haematopathological Diagnosis (1112) H Liu, A Bench, Y Huang, M Scott, JW Grant - M-Q D Addenbrooke's Hospital, Cambridge, United Kingdom 180 Establishment and Comprehensive Characterisation of MAVER-1, a New Mantle Cell Lymphoma Cell Line (1199) A Zamb, G Ott, F Antonucci, M Lestani, C Parolini, A Scarpa, F Menestrina, M Chilosi - University of Verona, Verona, Italy; University of Wuerzburg, Wuerzburg, Germany; 181 Application of the Bethesda Proposals for the Classification of Lymphoid and Non-Lymphoid Hematopoietic Neoplasms in Mice in Routine Diagnosis. An Evaluation of 584 Mice with Standardized Immunohistochemistry (1107) S Kunder, J Calzada-Wack, J Möller, L Quintanilla-Martinez - GSF-Research Center for Health and Environment, Neuherberg bei Munich, Germany 182 Expression of B-Cell Intracellular Signaling Molecules in CD20+ Classical Hodgkin's Lymphoma (1049) A Chiu, E Hyjek, A Chadburn, G Frizzera - Weill Medical College of Cornell University, New York, NY 183 Expression of Cyclooxygenase-2 in Reed-Sternberg Cells and Their Variants in Classical Hodgkin Lymphoma (1132) M Ohsawa, H Fukushima, M Hirayama, T Suekane, Y Sugama, N Shirai, T Inoue, Y Ikura, M Ueda - Osaka City University Graduate School of Medicine, Osaka City Genaral Hospital, Osaka, Japan 184 Prognostic Significance of Bcl-2 and MAL Expression in Classical Hodgkin Lymphoma (CHL) (1084) ED Hsi, SJ Sup, CA Alemany, P Elson, MA Alonso, B Pohlman - Cleveland Clinic Foundation, Cleveland, OH; Universidad Autonoma de Madrid, Madrid, Spain 185 Hodgkin Lymphoma Involving Waldeyer's Ring (1147) MP Quinones-Avila, AA Gonzalez-Longoria, JH Admirand, LJ Medeiros - Edgardo Rebagliati Hospital, Lima, Peru; The University of Texas MD Anderson Cancer Center, Houston, TX 186 Atypical T-Cell Populations in Nodular Lymphocyte Predominant Hodgkin Lymphoma (1149) A Rahemtullah, FI Preffer, NL Harris, RP Hasserjian - Massachusetts General Hospital, Harvard Medical School, Boston, MA 187 Quantitative Analysis of CD4/CD8 Ratios by Flow Cytometry as an Adjunct in Diagnosis of Hodgkin's Lymphomas (1200) G Zeng, A Ewton, Y Zu, C An, H Nishino, A Ponce de Lion, C Chang - Baylor College of Medicine, Houston, TX; The Methodist Hospital, Houston, TX; Indiana University School of Medicine, Indianapolis, IN